about
Accelerated Partial Breast Irradiation in Clinical PracticeStereotactic body radiotherapy for oligo-recurrence within the nodal area from colorectal cancerOligometastatic Prostate CancerSystematic review of patient reported quality of life following stereotactic ablative radiotherapy for primary and metastatic liver cancer.New challenges in high-energy particle radiobiology.Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrenceInstitutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases.Oligometastases in prostate cancer: restaging stage IV cancers and new radiotherapy options.Oligometastatic breast cancer: a shift from palliative to potentially curative treatment?Clinical Predictors of Survival for Patients with Stage IV Cancer Referred to Radiation OncologyStereotactic body radiotherapy (SBRT) in the management of extracranial oligometastatic (OM) disease.Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancerJapanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer.Ablative Therapies in Metastatic Breast Cancer: A Systematic Review.Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy[(18)F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results.Solitary recurrence of castration-resistant prostate cancer with low or undetectable levels of prostate specific antigen salvaged with local ablative radiation therapy: A case report.A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II)Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral ImmunotherapyThreshold doses and prediction of visually apparent liver dysfunction after stereotactic body radiation therapy in cirrhotic and normal livers using magnetic resonance imaging.Stereotactic radiation therapy for oligometastases or oligorecurrence within mediastinal lymph nodesClinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach.VERO® radiotherapy for low burden cancer: 789 patients with 957 lesionsPosttreatment Surveillance in Patients with Prolonged Disease-Free Survival After Resection of Colorectal Liver Metastasis.Eastern Canadian Gastrointestinal Cancer Consensus Conference 2016.New concepts and insights into the role of radiation therapy in extracranial metastatic disease.Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs.Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium.Stereotactic body radiotherapy for oligometastases confined to the para-aortic region: clinical outcomes and the significance of radiotherapy field and dose.Escaping death to quiescence: avoiding mitotic catastrophe after DNA damageIncreasing the Therapeutic Ratio of Stereotactic Ablative Radiotherapy by Individualized Isotoxic Dose Prescription.Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting.Spinal metastases: From conventional fractionated radiotherapy to single-dose SBRT.Is Stereotactic Body Radiotherapy (SBRT) in lymph node oligometastatic patients feasible and effective?A multinational report of technical factors on stereotactic body radiotherapy for oligometastases.The need for multidisciplinarity in specialist training to optimize future patient care.A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer.Therapeutic options in papillary thyroid carcinoma: current guidelines and future perspectives.Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies.Metastatic breast cancer: The Odyssey of personalization.
P2860
Q26776283-105AE6CF-D69D-400D-B318-03B0AC0FB6AAQ26866335-109532C6-486F-4399-9CC0-4664431CA64BQ28075182-6BDAA4BF-ABCF-42E5-B17C-D6A038106C18Q32173610-C308FF48-BF1E-4F33-A824-1F09AD7A659CQ33782346-E4291397-1CDD-490E-B06F-1BB9B0014ED8Q33789117-137ECB40-5B71-4825-ABFC-AAD17C6DAC53Q33823590-B46FBCE1-031C-4B20-9A87-D9BDD0D790D4Q34748629-7D2257DC-BAE4-4647-8C74-CED6E0B630C2Q35164247-8CE598EE-C92B-4681-A175-A60F6DF5856BQ35496632-DBBD1472-0B58-4412-9BE9-05D78C60F929Q36295437-616E356C-D44C-4F7B-A7E9-303E4BFA2051Q36300533-56C18224-03D1-4B20-9B10-72ACBE1B3838Q36324953-E3D505D0-C1BB-4DC2-A953-440F3766B24BQ36344204-0541635E-EBDB-4269-BA15-D0EFFC377BF9Q36483105-19BE0FAD-8EBC-487F-B0E1-FF93E096F6BEQ36489655-5238B09A-15C6-4503-9535-13611E2C503DQ36502875-96491529-5710-44DC-A500-BE4CCD1137BDQ36651935-28C6907D-6A1A-4FC9-849B-64C73CDF86CCQ36928875-DDEA280F-710D-4C3D-A0D0-63F19147E49DQ37025536-E8A2F6E3-0026-47D4-8DEF-70C96D27DC2FQ37109702-E478FA68-3B36-4D57-BBFC-521F31ED8817Q37187233-44A167D1-4188-4A3D-9138-BB30D171295EQ37301542-4CCD3850-BA68-464A-9DF7-3D28C87C1B23Q37306483-BF6C484F-A6B7-4164-82DD-99F453B088FAQ37524976-AFE61FFF-8360-4C59-AF70-C9A83879ED5EQ38153442-56F37D0D-ACFB-4704-90BF-5CA7E9A08AB9Q38223512-EBC4C37D-6610-4298-A7BB-4E370A3D178CQ38263008-A9B1E763-623D-4A35-B19D-82FBD159C67AQ38427413-DCD1C652-8F97-4C4C-BEE6-A05D9D03AEE7Q38607575-4D30ED23-40AF-4E16-B0AC-057A86F72C2AQ38609742-5C3E35B1-C738-487E-9230-FB98BEDF7A28Q38610286-3A4CC5EE-FC04-49BC-8787-AE432323584CQ38677022-C07C4880-595A-43D3-BFBF-7CAF6661F5A9Q38677028-D0A6490C-F005-4DD2-A0B7-D7BE6B31888AQ38762723-45542B12-5123-4BFE-B6B7-3F5F4D0D70B8Q38789457-50362AE1-6422-404A-A313-7AE77AC2127AQ38790915-6924E15E-1EAB-4986-A070-93D75EBF4932Q38844362-7F80AD65-B337-4F11-B4B1-E1A963023C7EQ38871523-A080FC16-8BE3-4AD0-A025-7468210EB939Q38901163-A5CDE295-EE1F-452A-B2E1-509A5FE815A2
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Stereotactic body radiotherapy for oligometastases.
@ast
Stereotactic body radiotherapy for oligometastases.
@en
Stereotactic body radiotherapy for oligometastases.
@nl
type
label
Stereotactic body radiotherapy for oligometastases.
@ast
Stereotactic body radiotherapy for oligometastases.
@en
Stereotactic body radiotherapy for oligometastases.
@nl
prefLabel
Stereotactic body radiotherapy for oligometastases.
@ast
Stereotactic body radiotherapy for oligometastases.
@en
Stereotactic body radiotherapy for oligometastases.
@nl
P2093
P50
P1433
P1476
Stereotactic body radiotherapy for oligometastases
@en
P2093
Christopher M Nutting
David P Dearnaley
Merina Ahmed
Peter J Ostler
Robert A Huddart
Vincent S Khoo
P304
P356
10.1016/S1470-2045(12)70510-7
P407
P577
2013-01-01T00:00:00Z